articleAnnals of Internal MedicineMay 19, 2009Closed access

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

KDKirsten de GrootLHLorraine HarperDRDavid R.W. JayneLFLuis Felipe Flores SuarezGGGina Gregorini

Sana Klinikum Offenbach

PubMed
Indexed incrossrefpubmed

Abstract

Background

Current therapies for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are limited by toxicity.

Objective

To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission.

Citation impact

945
total citations
FWCI
49.36
Percentile
100%
References
23
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Medicine
  • Cyclophosphamide
  • Interquartile range
  • Internal medicine
  • Leukopenia
  • Hazard ratio
  • Gastroenterology
  • Vasculitis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.